Demystify Meds for Moderate to Severe Crohn’s Disease
August 2023
We’re getting questions about how to manage moderate to severe Crohn’s disease.
Expect to see a “top-down” approach...with earlier use of biologics instead of waiting to see if meds such as sulfasalazine, mesalazine, or corticosteroids help.
Biologics include TNF-alpha blockers (adalimumab, etc)...anti-interleukin meds (ustekinumab, etc)...or selective adhesion blockers (vedolizumab, etc).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive